SBIR/STTR Research Award
ASSAYS FOR LDL RECEPTOR DEFECTS AND LDL CHOLESTEROL
Award amount
$49,648Program and phase
SBIR · Phase IAward year
1990Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Genetic Profiles
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
TWO ASSAYS THAT SHOULD BE USEFUL FOR THE CLINICAL DIAGNOSIS OF HYPERCHOLESTEROLEMIA WILL BE DEVELOPED. THE FIRST IS AN ASSAY FOR FAMILIAL HYPERCHOLESTEROLEMIA. IT IS BASED ON THEQUANTITATION OF LOW-DENSITY LIPOPROTEIN (LDL) RECEPTOR LEVELS IN PERIPHERAL BLOOD LYMPHOCYTES. LDL RECEPTOR EXPRESSION WILL BE MAXIMALLY INDUCED BY DEPLETION OF CELLULAR CHOLESTEROL, FOLLOWED BY QUANTITATION OF RECEPTOR NUMBER USING FLOW CYTOMETRY UTILIZING A SANDWICH ANTIBODY TECHNIQUE. THE ASSAY SHOULD BE SUFFICIENTLY SIMPLE AND INEXPENSIVE TO ALLOW RAPID SCREENING FOR THE DISEASE, WHICH OCCURS AT A FREQUENCY OF ABOUT 1/500 IN THE POPULATION. THE SECOND IS A DIRECT ASSAY FOR LDL CHOLESTEROL. IT IS BASED ON A SIMPLE LIPOPROTEIN FRACTIONATION SCHEME INVOLVINGREMOVAL OF THE OTHER LIPOPROTEIN SPECIES, VLDL AND HDL, USING SPECIFIC ANTIBODIES ON MAGNETIC BEADS. THE LDL CHOLESTEROL REMAINING IN SOLUTION CAN NOW BE DIRECTLY QUANTITATED BY STANDARD METHODS. THE ASSAY SHOULD BE USEFULFOR CLINICAL ANALYSIS AND DIAGNOSIS OF HYPERLIPIDEMIAS AND EVALUATION OF RISK OF CARDIOVASCULAR DISEASE.
Technology keywords
Not reported